Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20081
20111
20122
20131
20151
20171
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Boehringer Ingelheim2
Apollomics Inc.1
Arcus Biosciences, Inc.1
Cancer Therapeutics Research Group1
Eisai Inc.1
Iovance Biotherapeutics, Inc.1
Pfizer1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms12
Carcinoma, Non-Small-Cell Lung8
Adenocarcinoma of Lung4
Neoplasm Metastasis2
Pancreatic Neoplasms2
Adenocarcinoma, Bronchiolo-Alveolar1
Biliary Tract Neoplasms1
Brain Neoplasms1
Bronchial Neoplasms1
Carcinoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.